CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
Percutaneous radiologic gastrostomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03252509
NCT03252509N/ACompleted
CompareCT.gov

Outpatient Percutaneous Radiologic Gastrostomy in Patients With Head and Neck Tumors

Instituto Nacional de Cancer, Brazil·interventional·Posted Aug 17, 2017·Updated Apr 13, 2021

In Brief

A clinical study evaluating Percutaneous radiologic gastrostomy for Gastrostomy and 2 related conditions. Completed, enrolled 39 participants across 1 site.

Detailed Summary

This study intends to evaluate the security and success rate of large bore percutaneous radiologic gastrostomy in patients with head and neck tumors, as a outpatient procedure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastrostomy, Head and Neck Neoplasms, Malignant Neoplasm
CountriesBrazil
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedAug 17, 2017
Enrollment StartMar 20, 2017
Primary CompletionNov 21, 2018
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.9 years ago

Interventions

Percutaneous radiologic gastrostomyprocedure

Percutaneous radiologic gastrostomy: Under conscious sedation and local analgesia, the ultrasound is performed to determine abdominal structures. The stomach is distended using room air through a nasogastric catheter or a 5 French (Fr) catheter. Gastropexy is performed under fluoroscopic guidance. The stomach is accessed using a 18 gauge (G) needle. Guidewire is advanced to the stomach. Progressive tract dilatations until the size of the gastrostomy tube is achieved. The catheter is advanced through the peel-away sheath. The catheter's balloon is inflated with 10ml of distilled water. Iodine contrast is injected to confirm position. After the procedure, the patient is observed for 3 hours. If there are no complications, the patient is discharged.